OTCMKTS:INLX

Intellinetics (INLX) Stock Forecast, Price & News

$3.46

-0.04 (-1.14%)

(As of 06/8/2023 ET)

Compare

Today's Range: $3.43
▼
$3.50
50-Day Range: $3.46
▼
$4.25
52-Week Range: $3.25
▼
$11.94

Volume: 1,501 shs
Average Volume: 4,603 shs
Market Capitalization: $14.08 million

P/E Ratio: 115.33
Dividend Yield: N/A
Price Target: N/A

About Intellinetics (OTCMKTS:INLX) Stock

Intellinetics, Inc. is a holding company, which engages in the provision of document services and software solutions to private and public sectors. It operates through the Document Management and Document Conversion segments. The Document Management segment allows customers to capture and manage all documents across operations. The Document Conversion segment assists clients as a part of overall document strategy to convert documents from one medium to another, predominantly paper to digital, including migration to software solutions. The company was founded by A. Michael Chretien, Matthew L. Chretien, and Thomas D. Moss on October 3, 1997 and is headquartered in Columbus, OH.

Receive INLX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intellinetics and its competitors with MarketBeat's FREE daily newsletter.

INLX Stock News Headlines

May 25, 2023 | americanbankingnews.com

Q2 2023 Earnings Estimate for Intellinetics, Inc. Issued By Taglich Brothers (OTCMKTS:INLX)

May 15, 2023 | msn.com

Intellinetics GAAP EPS of $0.03 beats by $0.01, revenue of $4.19M beats by $0.24M

June 9, 2023 | UNKNOWN (Ad)

This NASDAQ Stock Is The Amazon Of Medical Supply

This Little Known Company IS Quickly Becoming The Amazon Of Medical Supply. Learn More Now

May 15, 2023 | finance.yahoo.com

Intellinetics Grows Revenues 55% in Q1 2023

May 8, 2023 | finance.yahoo.com

Intellinetics to Host First Quarter 2023 Financial Results Conference Call on May 15

April 24, 2023 | finance.yahoo.com

Intellinetics to Participate at 2023 MSBO Annual Conference & Exhibit Show

April 20, 2023 | barrons.com

Intellinetics to Participate at Taglich Brothers 19(th) Annual Investment Conference

April 18, 2023 | finance.yahoo.com

Intellinetics to Participate at Taglich Brothers 19th Annual Investment Conference

June 9, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

April 4, 2023 | americanbankingnews.com

Intellinetics, Inc. Forecasted to Post Q1 2023 Earnings of $0.02 Per Share (OTCMKTS:INLX)

April 3, 2023 | finance.yahoo.com

Intellinetics Named One of The Americas' Fastest Growing Companies by the Financial Times

April 2, 2023 | americanbankingnews.com

Q1 2024 Earnings Estimate for Intellinetics, Inc. (OTCMKTS:INLX) Issued By Taglich Brothers

March 31, 2023 | americanbankingnews.com

Intellinetics (OTCMKTS:INLX) Receives Speculative Buy Rating from Taglich Brothers

March 31, 2023 | americanbankingnews.com

Taglich Brothers Reaffirms Speculative Buy Rating for Intellinetics (OTCMKTS:INLX)

March 30, 2023 | finance.yahoo.com

Intellinetics, Inc. (PNK:INLX) Q4 2022 Earnings Call Transcript

March 29, 2023 | americanbankingnews.com

Intellinetics (OTCMKTS:INLX) Announces Earnings Results, Beats Estimates By $0.03 EPS

March 27, 2023 | finance.yahoo.com

Intellinetics Grows Annual Revenue 22% in 2022

March 27, 2023 | markets.businessinsider.com

Here's what Wall Street expects from Intellinetics's earnings

March 20, 2023 | finance.yahoo.com

Intellinetics to Host Fourth Quarter and Full Year 2022 Financial Results Conference Call on March 27

March 3, 2023 | ca.finance.yahoo.com

Intellinetics, Inc. (INLX) Interactive Stock Chart - Yahoo Finance

February 23, 2023 | msn.com

Brightcove (BCOV) Reports Q4 Loss, Lags Revenue Estimates

February 16, 2023 | finance.yahoo.com

Intellinetics to Participate in Winter Wonderland Best Ideas Virtual Investor Conference

February 14, 2023 | finance.yahoo.com

Intellinetics Completes Digital Conversion of Vital Records for Garden City, Michigan

January 26, 2023 | finance.yahoo.com

Intellinetics to Ring Closing Bell at The New York Stock Exchange

December 20, 2022 | finance.yahoo.com

Intellinetics Announces Retirement of Vice President of Products and Services Terry Buchanan

December 5, 2022 | finance.yahoo.com

Intellinetics Announces New Release of YellowFolder

November 16, 2022 | finance.yahoo.com

Intellinetics Names Experienced Audit and Reporting Expert John Guttilla to Board of Directors

See More Headlines

INLX Price History

30 days | 90 days | 365 days | Advanced Chart

INLX Company Calendar

Last Earnings: 5/15/2023
Today: 6/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: OTCMKTS
Industry: Prepackaged software
Sub-Industry: N/A
Sector: Computer and Technology
Current Symbol: OTCMKTS:INLX
CUSIP: N/A
CIK: 1081745
Web: www.intellinetics.com
Phone: (614) 921-8170
Fax: N/A
Employees: 93
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.03
Trailing P/E Ratio: 115.33
Forward P/E Ratio: 26.62
P/E Growth: N/A
Net Income: $20,000.00
Net Margins: 1.02%
Pretax Margin: 1.01%
Return on Equity: 5.92%
Return on Assets: 2.52%

Debt

Debt-to-Equity Ratio: 0.32
Current Ratio: 0.84
Quick Ratio: 0.82

Sales & Book Value

Annual Sales: $14.02 million
Price / Sales: 1.00
Cash Flow: $0.25 per share
Price / Cash Flow: 14.12
Book Value: $2.10 per share
Price / Book: 1.65

Miscellaneous

Outstanding Shares: 4,070,000
Free Float: 3,746,000
Market Cap: $14.08 million
Optionable: Not Optionable
Beta: 0.38

Key Executives

James F. DeSocio
President, Chief Executive Officer & Director

Mike Beck
Vice President-Operations

Joe Spain
Chief Financial Officer & Treasurer

Matt Chretien
Secretary, Director, CTO & Chief Strategy Officer

Thomas D. Moss
Vice President-Research & Development

Key Competitors

View All Competitors

Institutional Ownership

Susquehanna International Group LLP
Bought 17,691 shares on 5/16/2023
Ownership: 0.434%

View All Institutional Transactions

INLX Stock - Frequently Asked Questions

Should I buy or sell Intellinetics stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Intellinetics in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" INLX shares.
View INLX analyst ratings or view top-rated stocks.
How have INLX shares performed in 2023?: Intellinetics' stock was trading at $4.27 at the beginning of the year. Since then, INLX stock has decreased by 19.0% and is now trading at $3.46.
View the best growth stocks for 2023 here.
How were Intellinetics' earnings last quarter?: Intellinetics, Inc. (OTCMKTS:INLX) released its quarterly earnings data on Monday, May, 15th. The company reported $0.03 earnings per share for the quarter, topping the consensus estimate of $0.02 by $0.01. The company had revenue of $4.19 million for the quarter, compared to the consensus estimate of $3.95 million. Intellinetics had a trailing twelve-month return on equity of 5.92% and a net margin of 1.02%.
What other stocks do shareholders of Intellinetics own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Intellinetics investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Kopin (KOPN), Onconova Therapeutics (ONTX), OPKO Health (OPK), Precipio (PRPO), Selecta Biosciences (SELB), Sierra Oncology (SRRA) and T2 Biosystems (TTOO).

What is Intellinetics' stock symbol?: Intellinetics trades on the OTCMKTS under the ticker symbol "INLX."
Who are Intellinetics' major shareholders?: Intellinetics' stock is owned by a number of retail and institutional investors. Top institutional investors include Susquehanna International Group LLP (0.43%).
View institutional ownership trends.
How do I buy shares of Intellinetics?: Shares of INLX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Intellinetics' stock price today?: One share of INLX stock can currently be purchased for approximately $3.46.
How much money does Intellinetics make?: Intellinetics (OTCMKTS:INLX) has a market capitalization of $14.08 million and generates $14.02 million in revenue each year. The company earns $20,000.00 in net income (profit) each year or $0.03 on an earnings per share basis.
How can I contact Intellinetics?: Intellinetics' mailing address is 2190 DIVIDEND DRIVE, COLUMBUS OH, 43228. The official website for the company is www.intellinetics.com. The company can be reached via phone at (614) 921-8170 or via email at contactus@intellinetics.com.

This page (OTCMKTS:INLX) was last updated on 6/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial